WC
HALO icon

Weil Company’s Halozyme HALO Stock Holding History

Weil Company’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-40
Closed -$1K – 201
2019
Q3 		$1K Buy
+40
New +$659 ﹤0.01% 375

Other funds holding HALO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Weil Company's HALO Position: Q4 2019 in Review

Weil Company sold out of Halozyme (HALO) in Q4 2019, closing a stake of 40 shares — an estimated $1K sold.

Weil Company first reported a position in HALO in Q3 2019 and held it in 1 quarter. The position peaked at $1K in Q3 2019. 224 funds tracked by Wall St. Rank hold HALO as of Q4 2019.

  • Weil Company reported no remaining Halozyme position as of Q4 2019 after selling out during the quarter.
  • Weil Company sold 40 Halozyme shares in Q4 2019, an estimated $1K.
  • Weil Company first reported a position in Halozyme in Q3 2019 and held it in 1 quarter.
  • Weil Company's Halozyme position peaked at $1K in Q3 2019.
  • 224 funds tracked by Wall St. Rank held Halozyme as of Q4 2019.

Based on Weil Company's 13F filing for Q4 2019, filed 13 Feb 2020.